Invenra

Health Care · Biologics & Biosimilars

Overview

Invenra delivers high-quality antibody discovery and engineering solutions, including monoclonal, bispecific, and trispecific antibodies, ready to advance your research and development pipeline.

Key facts

These are the key facts about Invenra on Alion as of Nov 13, 2026. Invenra is headquartered in Madison, United States. It has raised $20.1M in 6 funding rounds. The latest round is Venture - Series Unknown of $7.1M, announced in 2018.

Headquarters
Madison, United StatesAlion company profile, updated Nov 12, 2026
Employees
10+Alion company profile, an estimated range
Total raised
$20.1MSum of 6 equity rounds Alion knows
Latest round
Venture - Series Unknown · $7.1M · Oct 1, 2018SEC Form D filing · sec.gov
Official records

Funding and backers

Total raised
$20.1M
7 rounds on record
Latest round
$7.1M
Venture round · Oct 2018 · 8 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
97 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 1, 2018 Raised a round Venture round $7.1M · SEC Form D Sep 20, 2017 Raised a round Venture round $2.9M · SEC Form D Jul 12, 2016 Raised a round Venture round $3M · SEC Form D Aug 13, 2015 Raised a round Venture round $2M · SEC Form D Jan 14, 2015 Raised a round Venture round $2M · SEC Form D Feb 8, 2013 Raised a round Venture round $3M · SEC Form D Jan 6, 2012 Took on debt financing $1.2M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2018 $7.1M — SEC Form D
Venture round Sep 2017 $2.9M — SEC Form D
Venture round Jul 2016 $3M — SEC Form D
Venture round Aug 2015 $2M — SEC Form D
Venture round Jan 2015 $2M — SEC Form D
Venture round Feb 2013 $3M — SEC Form D
Debt Financing Jan 2012 $1.2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Invenra Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Roland GreenExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
High-Tech Gründerfonds
backs Alentis Therapeutics, Evlabio
8VC
backs Alloy Therapeutics
Oxford Science Enterprises
backs BarinthusBio
ARCH Venture Partners
backs Protillion Biosciences
Cambridge Angels
backs Antiverse
RA Capital Management
backs Alentis Therapeutics
Similar startupsby what they do, their industry and backers
Alloy TherapeuticsSeries E $40M · 6 mo ago · Founded 2020 · 51-200 employees · 6 roles
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…
Alentis TherapeuticsSeries D $181.4M · 2 yr ago · Founded 2019 · 51-200 employees
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Evlabio11-50 employees
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody…
Protillion BiosciencesSeries A $18M · 3 yr ago · 11-50 employees · 1 role
Explore Therapeutic Protein Libraries. For decades, therapeutic antibody discovery and optimization has been a shot in the Dark With the…
AntiverseVenture round · 5 mo ago · Founded 2017
Antiverse combines generative AI and advanced antibody discovery to design functional, developable biologics for challenging drug targets.
BarinthusBio
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.

Financials

Total raised
$21.3M
Latest round
Venture - Series Unknown
Funding rounds
7
Funding rounds
Round Announced Amount
Venture - Series Unknown 2018 $7.1M Details
Venture - Series Unknown 2017 $2.9M Details
Venture - Series Unknown 2016 $3M Details
Venture - Series Unknown 2015 $2M Details
Venture - Series Unknown 2015 $2M Details
Venture - Series Unknown 2013 $3M Details
Debt Financing 2012 $1.2M Details

People

Roland Green
Executive Officer, Director
SEC Form D
Emile Nuwaysir
Director
SEC Form D
Stan Rose
Director
SEC Form D
David Snyder
Director
SEC Form D
Richard Lesniewski
Director
SEC Form D
Paul Weiss
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Madison United States
HQ
Invenra Inc.
10-50 est. staff
5510 Element Way, Suite 400, Madison, WI 53711
company site

How to cite this page

Alion, "Invenra: key facts", as of Nov 13, 2026. https://alion.io/company/invenra

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0